Agents acting on the Biosynthesis, Storage, Release and Elimination of Catecholamines Flashcards
Overview of the Sympathetic Efferent System
Preggl neuron: ACh–> ggl
Post ggl neuron (nor)adrenergi neuron–> NA to innervated tissue
Preggl neuron: ACh-> Adrenal Medulla
Adrenal Medulla then releases A, NA
Biosynthesis of NA and other Catecholamines
Tyrosine– Tyrosine hydroxylase–> DOPA
DOPA—DOPA decarboxylase–> Dopamine
Dopamine– Dopamine b hydroxylase–> NA
NA– Phenylethanolamine N-methyltransferase–> Adrena.
Phenylethanolamine N-methyltransferase: found in Adrenal Medulla
Endogenous catecholamines:
Dopamine, NA, Adrenaline
Enzymes of Catecholamine Biosynthesis
Tyrosine hydroxylase
Cytosolic
Rate limiting
Subject to end product inhibition
L-tyrosine is actively taken up into adrenergic nerve ending for this
Enzymes of Catecholamine Biosynthesis
DOPA decarboxylase
Cytosolic
Non specific
Also involved in histamine and 5HT synthesis
Enzymes of Catecholamine Biosynthesis
Dopamine b hydroxylase
Vesicular
Released during AP induced exocytosis but not taken up
–> Indicator of sympathetic activity
Inhibited by disulfiram
Enzymes of Catecholamine Biosynthesis
Phenylethanolamine N-methyltransferase
Found in Adrenal Medulla and Brain
Induced by cortisol
Drugs Influencing Catecholamine Biosynthesis
a- Methylthyroxine
Taken up actively -> NA nerve endings and adrenal medulla
Inhibits tyrosine hydroxylase-> diminishes synthesis of NA and Adrenaline
Used in phaeochromocytoma th
Drugs Influencing Catecholamine Biosynthesis
L-DOPA
Used to replace deficient dopamine in Parkinsons
Drugs Influencing Catecholamine Biosynthesis
Carbidopa, Benserazide
DOPA decarboxylase inhibitors
Don’t enter CNS
Co-applied with L-DOPA to decrease its peripheral SEs
Drugs Influencing Catecholamine Biosynthesis
a-Methyldopa
Taken up actively into NA nerve endings
Acts as false/alternative substrate for DOPA decarboxylase–> forms a-methyldopamine: alternative substrate for dopamine-b-hydroxylase–> a-methylNA
In addition, less NA is produced due to competition
a-methylNA is a false NT:
higher affinity to a2 R and less effect at a1 R compared
to NA–> reduced exocytotic transmitter release via
prejunctional a2 R
a-methylNA is also formed in central NA neurons
Diminishes activity of vasomotor center via a2 R
–> central sympatholytic
Decrease BP
Rarely used as antihypertensive due to SEs
No evidence for teratogenicity: used in pregnant patients
Vesicular Storage of NA
NET transports NA from synaptic cleft-> cytosol
NE/Na symporter
Here some NE is degraded by MAO
VMAT accumulates NA in vesicles: NE in; H out
–> 2ary active H-monoamine antiporter
Driven by H ATPase (H into cell): actively accumulates H
in cell
VMAT can also accumulate dopamine, serotonin
VMAT isoforms
VMAT1: NA sympathetic nerve endings (peripheral)
VMAT2: monoaminergic neurons of CNS
What is stored in the vesicles
NA stored with ..... in vesicles dopamine dopamine b hydroxylase chromogranin A ATP (co transmitter)
Drugs Affecting NA Storage
Reserpine
Irreversible inhibitor of VMAT 1 and VMAT 2
Enters nerve ending via diffusion
Inhibits vesicular uptake of dopamine and NA
–> both are metabolised by MAO
Effect: depletion of NA and dopamine in nerve endings
Can also cause transmitter depletion in (Nor)adrenergic, dopaminergic, serotinergic neurons in CNS–> sedation, parkinsonism, depression
Historical use: Th of hypertension
Drugs Affecting NA Storage
Tetrabenazine
VMAT 2 Inhibitor
Used in Huntington’s Chorea
Drugs Affecting NA Storage
Indirectly acting sympathomimmetics
Adrenergic neuron blockers
Are alternative substrates for VMAT